Which one, gastric parietal cell antibody positivity or hyperhomocysteinemia, is a better biomarker to predict oral mucosal disease patients with vitamin B12 deficiency?

ANDY SUNJULIA YU-FONG CHANGCHUN-PIN CHIANG2021-10-152021-10-1520210929-6646https://www.scopus.com/inward/record.uri?eid=2-s2.0-85090466391&doi=10.1016%2fj.jfma.2020.08.017&partnerID=40&md5=e57ef2928debaa797eae37b1e9b2611dhttps://scholars.lib.ntu.edu.tw/handle/123456789/584780Which one, gastric parietal cell antibody positivity or hyperhomocysteinemia, is a better biomarker to predict oral mucosal disease patients with vitamin B12 deficiency?letter10.1016/j.jfma.2020.08.017328550352-s2.0-85090466391